When these drugs were approved in the 1990s, their labels noted sexual side effects that normalized after treatment ended. In 2011, the FDA updated the labels to warn of persistent, posttreatment erectile dysfunction.
Akshaya Bhagavathula
TheFDA update includes:
The Propecia label will include libido, ejaculation, and orgasm disorders that persist after treatment ends.
The Proscar label will include decreased libido that persists posttreatment.
Both labels will note reports of male infertility or poor semen quality that improved after drug discontinuation.
0 votes
0 thanks
Bachar Jammal
Ps. Trans pl use this drug to keep them with feminine features; like adipose and hair distribution, along with antiprogesteron therapy.
1 votes
0 thanks
- Badges
- Science topic
- Similar topics
- Chemistry
- Pharmacology
More Akshaya Bhagavathula's questions See All
Similar questions and discussions